查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2046139

血液採集市場－全球產業規模、佔有率、趨勢、機會和預測：按採集地點、應用、方法、最終用途、地區和競爭格局分類，2021-2031年

Blood Collection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Collection Site, By Application, By Method, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 192 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球血液採集市場預計將從 2025 年的 108.6 億美元成長到 2031 年的 161.3 億美元，複合年成長率為 6.82%。

該市場涵蓋用於診斷和輸血的專用設備，例如真空管、針頭和血袋。主要成長要素包括癌症等慢性疾病負擔日益加重，以及人口老化導致醫療保健需求增加。此外，創傷病例的增加和新興國家醫療基礎設施的持續發展也推動了對安全採血技術的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 108.6億美元
市場規模：2031年 161.3億美元
複合年成長率：2026-2031年 6.82%
成長最快的細分市場 醫院
最大的市場 北美洲

儘管前景廣闊，但該行業仍面臨許多挑戰，例如供應鏈長期不穩定和捐血者短缺。血液和生物療法促進協會（AAABB）發布的2025年數​​據顯示，O型陰性血的即時供應通常需要48小時或更長時間的前置作業時間，凸顯了嚴重的物流難題。這些效率低下的問題，加上為確保捐血者安全而必須嚴格遵守監管規定所帶來的高成本，可能會阻礙市場擴張，尤其是在資源匱乏的環境中。

市場促進因素

文明病和慢性病的日益普遍是全球血液採集市場的主要促進因素。糖尿病和癌症等疾病需要定期採集血液樣本用於診斷、治療追蹤和疾病管理，導致血液採集耗材消耗量龐大。例如，美國癌症協會於2025年1月發布的《2025年癌症事實與數據》報告預測，美國將新增約2,041,910例癌症病例，凸顯了腫瘤學領域對可靠血液採集工具的迫切需求。如此沉重的疾病負擔迫使醫療機構儲備大量針頭和真空採血管等必需耗材，以確保診斷服務的持續性。

同時，各國政府鼓勵自願捐血的計畫正在透過加強供應鏈以滿足輸血需求來重塑市場格局。各國衛生組織正加大對血液採集基礎設施的投入，以確保為緊急創傷治療和外科手術提供安全的血液儲備。世界衛生組織（世衛組織）於2025年5月發布的《血液安全與供應》概況介紹顯示，屆時全球將有約1.1854億人次捐血，這意味著需要大量血液採集設備的醫療活動。如此龐大的血液採集量為各大公司帶來了可觀的收入。例如，貝克頓·迪金森公司報告稱，其生命科學部門在2025年第一季創造了13億美元的收入，這主要得益於血液採集產品的強勁銷售量。

市場挑戰

全球血液採集市場面臨的主要障礙之一是捐血長期短缺。這個問題直接限制了市場擴張，因為血液採集量減少，而血液採集量是影響血袋、真空採血管和針頭等一次性用品消耗量的主要因素。由於市場高度依賴血液採集量，捐血參與度的下降會立即導致這些一次性用品的採購量減少。此外，長期短缺也為採購週期帶來了不確定性，迫使製造商應對波動不定的訂單模式，而不是受益於醫療基礎設施改善和人口老化帶來的正常、穩定的需求成長。

近期統計數據顯示，血液供應嚴重短缺，凸顯了這種結構性不穩定性。 2025年2月，美國血液中心報告稱，美國南部25%的血液中心庫存不足，僅夠維持一天的供應。如此嚴重的短缺表明，儘管臨床對血液製品的需求不斷成長，但由於無法獲得足夠的捐血者，捐血採集設備的實際市場潛力受到限制，進而阻礙了參與企業的收入成長。

市場趨勢

遠端和居家採血模式的興起，透過分散檢體採集流程，從根本上改變了傳統的採血方式。微量採樣設備的普及推動了這一轉變，患者可以自行採集毛細血管血，從而減輕醫院的後勤負擔，並提高分散式臨床試驗的依從性。轉向自我採集不僅是為了方便，它更代表了擴充性的商業策略，製造商正積極探索這項策略以滿足日益成長的醫療保健消費需求。這些以患者為中心的解決方案的迅速普及，從其顯著的商業性成功中可見一斑。例如，Tasso在2025年10月的新聞稿中宣布，其血液採集設備的銷售量已突破200萬台，凸顯了遠端採樣技術的強大市場滲透率。

同時，市場正經歷著向專為基因組學和液態生物檢體應用而設計的專用保存管的顯著轉變。分子診斷技術的進步推動了對配備獨特防腐劑的採血管的需求激增，這些防腐劑能夠穩定遊離DNA (cfDNA)，並防止運輸過程中因白血球溶解而造成的基因組污染。這一趨勢正在改變採血管的用途，使其從單純的耗材轉變為對非侵入性產前檢測和腫瘤診療流程至關重要的高價值醫療設備。對先進採血管的需求與診斷檢查室基因組檢測的快速成長密切相關。例如，Natera公司於2025年11月發布的2025年第三季財報顯示，光是該季度就進行了約21.1萬例腫瘤檢測，較去年同期成長53.9%。這導致了專用穩定管使用量的相應成長。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球血液採集市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依採集部位（靜脈採集{針頭及注射器、採血管、血袋等}，微血管採集{採血針、微量採血管、微量血球比容管、加溫裝置等}）
    • 透過應用（診斷、治療）
    • 按方法（手動、自動）
    • 依最終用途（醫院、血庫、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美血液採集市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲血液採集市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區血液採集市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲血液採集市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲血液採集市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球血液採集市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • NIPRO Medical Corporation
  • Abbott Laboratories Inc.
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Qiagen NV
  • Medtronic plc
  • FL Medical srl
  • SARSTEDT AG & Co. KG
  • Greiner Holding AG
  • Haemonetics Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23957

The Global Blood Collection Market is projected to expand from USD 10.86 Billion in 2025 to USD 16.13 Billion by 2031, reflecting a CAGR of 6.82%. This market encompasses specialized apparatus such as vacuum tubes, needles, and blood bags utilized for diagnostic and transfusion purposes. The primary growth factors include the increasing burden of chronic diseases like cancer, alongside an aging demographic that demands frequent medical care. Furthermore, the rising occurrence of trauma cases and the ongoing development of healthcare infrastructure in emerging nations continue to reinforce the demand for secure collection technologies.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 10.86 Billion
Market Size 2031USD 16.13 Billion
CAGR 2026-20316.82%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Despite these growth prospects, the sector encounters obstacles such as enduring supply chain instability and a shortage of donors. Data from the Association for the Advancement of Blood and Biotherapies in 2025 indicated that securing type O negative blood for immediate use often necessitated a lead time of 48 hours or more, underscoring severe logistical difficulties. These inefficiencies, coupled with the high costs associated with strict regulatory compliance for donor safety, threaten to restrict market expansion, particularly in resource-constrained environments.

Market Driver

The rising prevalence of lifestyle-related and chronic diseases serves as a major driver for the Global Blood Collection Market. Ailments such as diabetes and cancer require regular blood sampling for diagnosis, treatment tracking, and disease management, thereby maintaining a high consumption rate of collection supplies. For example, the 'Cancer Facts & Figures 2025' report by the American Cancer Society, released in January 2025, projects approximately 2,041,910 new cancer diagnoses in the United States, highlighting the urgent necessity for dependable collection tools in oncology. This heavy disease burden forces healthcare facilities to maintain substantial inventories of essential items, including needles and vacuum tubes, to ensure uninterrupted diagnostic services.

Concurrently, government programs encouraging voluntary blood donation are reshaping the market by fortifying supply chains for transfusion needs. National health bodies are increasingly funding collection infrastructure to guarantee safe blood reserves for emergency trauma and surgical procedures. According to the World Health Organization's 'Blood safety and availability' fact sheet from May 2025, roughly 118.54 million blood donations are collected globally, demonstrating the massive scale of operations requiring collection devices. This volume generates significant revenue for leading manufacturers; for instance, Becton, Dickinson and Company reported that their Life Sciences segment earned $1.3 billion in the first quarter of 2025, a figure driven largely by strong sales volumes of blood collection products.

Market Challenge

A significant obstacle hindering the Global Blood Collection Market is the persistent shortage of blood donors. This issue directly suppresses market expansion by lowering collection volumes, which act as the primary determinant for the consumption of disposable items like blood bags, vacuum tubes, and needles. Since the market relies heavily on volume, any decrease in donor participation results in an immediate reduction in the procurement of these single-use devices. Additionally, chronic shortages introduce unpredictability into procurement cycles, compelling manufacturers to navigate volatile ordering patterns instead of benefiting from the consistent demand growth usually associated with improved healthcare infrastructure and an aging population.

This structural instability is emphasized by recent statistics revealing critical inventory gaps. In February 2025, America's Blood Centers reported that 25% of blood centers in the southern United States were operating with critical supply levels of one day or less. Such severe shortages illustrate that, despite the growing clinical need for blood products, the actual market potential for collection equipment is limited by the failure to secure adequate donor turnout, which directly impedes revenue growth for industry participants.

Market Trends

The rise of Remote and At-Home Blood Collection Models is fundamentally transforming traditional phlebotomy by decentralizing the process of sample acquisition. This shift is supported by the use of microsampling devices that enable patients to independently collect capillary blood, thereby easing the logistical strain on hospitals and enhancing compliance for decentralized clinical trials. Moving toward self-administration represents a scalable operational strategy that manufacturers are actively pursuing to address growing healthcare consumerism, rather than a mere convenience. The rapid adoption of these patient-focused solutions is evident in significant commercial achievements; for example, Tasso, Inc. announced in an October 2025 press release that it had reached a milestone of selling two million blood collection devices, highlighting the strong market penetration of remote sampling technologies.

At the same time, the market is undergoing a notable shift toward Specialized Preservation Tubes designed for Genomics and Liquid Biopsy applications. With advancements in molecular diagnostics, there is a crucial need for collection tubes equipped with proprietary preservatives that stabilize cell-free DNA (cfDNA) and prevent genomic contamination caused by white blood cell lysis during transit. This trend transitions the blood collection sector from basic consumables to high-value medical devices vital for non-invasive prenatal testing and oncology workflows. The demand for these advanced tubes tracks closely with the surging volume of genomic assays in diagnostic labs; for instance, Natera, Inc.'s 'Third Quarter 2025 Financial Results' from November 2025 reported approximately 211,000 oncology tests performed in that quarter alone-a 53.9% year-over-year increase-fueling a concurrent rise in the use of specialized stabilization tubes.

Key Market Players

  • NIPRO Medical Corporation
  • Abbott Laboratories Inc.
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Qiagen N.V
  • Medtronic plc
  • FL Medical s.r.l.
  • SARSTEDT AG & Co. KG
  • Greiner Holding AG
  • Haemonetics Corporation

Report Scope

In this report, the Global Blood Collection Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Collection Market, By Collection Site

  • Venous
  • Capillary

Blood Collection Market, By Application

  • Diagnostics
  • Treatment

Blood Collection Market, By Method

  • Manual
  • Automated

Blood Collection Market, By End-use

  • Hospitals
  • Blood Banks
  • Others

Blood Collection Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Collection Market.

Available Customizations:

Global Blood Collection Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Collection Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Collection Site (Venous {Needles and Syringes, Blood collection Tubes, Blood Bags, Others}, Capillary {Lancets, Micro-Container Tubes, Micro-Hematocrit Tubes, Warming Devices, Others})
    • 5.2.2. By Application (Diagnostics, Treatment)
    • 5.2.3. By Method (Manual, Automated)
    • 5.2.4. By End-use (Hospitals, Blood Banks, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Blood Collection Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Collection Site
    • 6.2.2. By Application
    • 6.2.3. By Method
    • 6.2.4. By End-use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood Collection Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Collection Site
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Method
        • 6.3.1.2.4. By End-use
    • 6.3.2. Canada Blood Collection Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Collection Site
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Method
        • 6.3.2.2.4. By End-use
    • 6.3.3. Mexico Blood Collection Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Collection Site
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Method
        • 6.3.3.2.4. By End-use

7. Europe Blood Collection Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Collection Site
    • 7.2.2. By Application
    • 7.2.3. By Method
    • 7.2.4. By End-use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Blood Collection Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Collection Site
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Method
        • 7.3.1.2.4. By End-use
    • 7.3.2. France Blood Collection Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Collection Site
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Method
        • 7.3.2.2.4. By End-use
    • 7.3.3. United Kingdom Blood Collection Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Collection Site
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Method
        • 7.3.3.2.4. By End-use
    • 7.3.4. Italy Blood Collection Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Collection Site
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Method
        • 7.3.4.2.4. By End-use
    • 7.3.5. Spain Blood Collection Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Collection Site
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Method
        • 7.3.5.2.4. By End-use

8. Asia Pacific Blood Collection Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Collection Site
    • 8.2.2. By Application
    • 8.2.3. By Method
    • 8.2.4. By End-use
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Blood Collection Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Collection Site
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Method
        • 8.3.1.2.4. By End-use
    • 8.3.2. India Blood Collection Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Collection Site
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Method
        • 8.3.2.2.4. By End-use
    • 8.3.3. Japan Blood Collection Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Collection Site
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Method
        • 8.3.3.2.4. By End-use
    • 8.3.4. South Korea Blood Collection Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Collection Site
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Method
        • 8.3.4.2.4. By End-use
    • 8.3.5. Australia Blood Collection Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Collection Site
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Method
        • 8.3.5.2.4. By End-use

9. Middle East & Africa Blood Collection Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Collection Site
    • 9.2.2. By Application
    • 9.2.3. By Method
    • 9.2.4. By End-use
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Blood Collection Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Collection Site
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Method
        • 9.3.1.2.4. By End-use
    • 9.3.2. UAE Blood Collection Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Collection Site
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Method
        • 9.3.2.2.4. By End-use
    • 9.3.3. South Africa Blood Collection Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Collection Site
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Method
        • 9.3.3.2.4. By End-use

10. South America Blood Collection Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Collection Site
    • 10.2.2. By Application
    • 10.2.3. By Method
    • 10.2.4. By End-use
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Blood Collection Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Collection Site
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Method
        • 10.3.1.2.4. By End-use
    • 10.3.2. Colombia Blood Collection Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Collection Site
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Method
        • 10.3.2.2.4. By End-use
    • 10.3.3. Argentina Blood Collection Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Collection Site
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Method
        • 10.3.3.2.4. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Blood Collection Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. NIPRO Medical Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Abbott Laboratories Inc.
  • 15.3. Becton, Dickinson and Company
  • 15.4. Terumo Corporation
  • 15.5. Qiagen N.V
  • 15.6. Medtronic plc
  • 15.7. FL Medical s.r.l.
  • 15.8. SARSTEDT AG & Co. KG
  • 15.9. Greiner Holding AG
  • 15.10. Haemonetics Corporation

16. Strategic Recommendations

17. About Us & Disclaimer